Top 100 scientists can be ranked globally or specific to the following regions including Africa, Asia, Europe, North America, Latin America, Oceania, Arab League, ASEAN, EECA, and BRICS based on total H-index scores without any breakdown by subject areas. Top 100 rankings in the world, in a continent, or a region include standardized subjects areas of Agriculture & Forestry, Arts, Design and Architecture, Business & Management, Economics & Econometrics, Education, Engineering & Technology, History, Philosophy, Theology, Law/Law and Legal Studies, Medical and Health Sciences, Natural Sciences, Social Sciences, Art and Humanities Rankings and Social Sciences and Humanities Rankings BETA VERSION. Subject field ranking in world, region, country and university is beta version since subject field "others" (873,690 scientists profile whose branch cannot be determined, not yet edited or determined) is excluded, so the ranking will change as the others fields are edited. Please note that. Subjects indicated as “ * others ” will not be included in the ranking by regions and subjects.
Parkinson
Neuroimaging
Clinical Pharmacology
Clinical trials
Neuroprotection
Metrics
H-Index
i10 Index
Citation
128
482
70,502
Pharmacoepidemiology
abuse
dependence
CNS drugs
Metrics
H-Index
i10 Index
Citation
65
301
16,702
Metrics
H-Index
i10 Index
Citation
45
104
7,890
* Rankings
Ranking Based
On Selection: 4
Drug utilization
Aging
Dementia
Pharmacoepidemiology
Metrics
H-Index
i10 Index
Citation
25
41
2,830
* Rankings
Ranking Based
On Selection: 5
Pharmacovigilance
drug safety
oncology
Metrics
H-Index
i10 Index
Citation
24
35
2,481
* Rankings
Ranking Based
On Selection: 6
Pharmacoepidemiology
Drug Safety
Electronic healthcare databases
SNDS
Drug exposure measurement
Metrics
H-Index
i10 Index
Citation
24
31
2,068
* Rankings
Ranking Based
On Selection: 7
pharmacologie
Metrics
H-Index
i10 Index
Citation
2
1
24
Olivier Rascol
Université de Toulouse III
Toulouse, France
Metrics
H-Index
i10 Index
Citation Counts
128
482
70,502
Parkinson
Neuroimaging
Clinical Pharmacology
Clinical trials
Neuroprotection
Lapeyre-Mestre Maryse
Université de Toulouse III
Toulouse, France
Metrics
H-Index
i10 Index
Citation Counts
65
301
16,702
Pharmacoepidemiology
abuse
dependence
CNS drugs
Jalloul Bouajila
Université de Toulouse III
Toulouse, France
Metrics
H-Index
i10 Index
Citation Counts
45
104
7,890
Adeline Gallini
Université de Toulouse III
Toulouse, France
Metrics
H-Index
i10 Index
Citation Counts
25
41
2,830
Drug utilization
Aging
Dementia
Pharmacoepidemiology
Emmanuelle Bondon Guitton
Université de Toulouse III
Toulouse, France
Metrics
H-Index
i10 Index
Citation Counts
24
35
2,481
Pharmacovigilance
drug safety
oncology
Aurore Palmaro
Université de Toulouse III
Toulouse, France
Metrics
H-Index
i10 Index
Citation Counts
24
31
2,068
Pharmacoepidemiology
Drug Safety
Electronic healthcare databases
SNDS
Drug exposure measurement
Marie Pajiep
Université de Toulouse III
Toulouse, France
Metrics
H-Index
i10 Index
Citation Counts
2
1
24